|
WO0054051A1
|
|
Integrated assay for organ function, drugs and/or metabolites
|
|
US6024919A
|
|
Sonic treatment to selectively reduce the void volume of sintered polymers
|
|
US5885839A
|
|
Methods of determining initiation and variable end points for measuring a chemical reaction
|
|
US5639672A
|
|
Electrochemical determination of fructosamine
|
|
US5695949A
|
|
Combined assay for current glucose level and intermediate or long-term glycemic control
|
|
US5725774A
|
|
Whole blood separation method and devices using the same
|
|
US5470752A
|
|
Multi-layer devices and methods of assaying for fructosamine
|
